News
Weightwatchers and bariatric surgery had limited effects on the obese brain, but GLP-1s like Ozempic may mean new hope in ...
Estrogen generated in the brain may play a role in regulating appetite, potentially opening new avenues for treating obesity.
I worry about how these changes, which are occurring at the age of 13 or 14, might affect them later in life,” the study’s ...
Queen Latifah opens up about obesity and heart health risks for public awareness campaign, Truth About Weight.
Zepbound outperformed Nordisk's Wegovy in terms of weight loss, solidifying Lilly's leadership in the anti-obesity drug ...
However, many on Wall Street believe that better days lie ahead for Novo Nordisk. Analysts expect this obesity drug stock to ...
A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial ...
A survey of adults living with obesity and their physicians across seven countries reveals a high disconnect between their ...
Novo Nordisk CEO's ouster signals stiff competition in the obesity market, getting dominated by Eli Lilly, with Roche, ...
Annual Congress, CureGene Pharmaceuticals ("CureGene") announced late-breaking preclinical results for its investigational liver-targeted thyroid hormone receptor beta (THR-β) prodrug, CG-0416.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback